FIELD: medicine.
SUBSTANCE: invention relates to experimental medicine and can be used for correction of hypogonadism in animals in modeling acute spinal cord injury. That is ensured by the intravenous administration of the aqueous solution of 0.5 % preparation of D-asparagine intravenously once daily in a course dose of 21.7 mg/kg from 3rd to 5th day of the acute spinal cord injury modeling.
EFFECT: invention allows increasing testosterone concentration and reducing the degree of testis atrophy.
1 cl, 4 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PREPARATION FOR GLIAL SCARS PREVENTION | 2017 |
|
RU2651756C1 |
| HYDROGEL FOR CORRECTING THE POST-TREPANATION DEFECT OF THE SKULL | 2017 |
|
RU2666595C1 |
| HYDROGEL TO SUBSTITUTE DEFECTS OF BIOLOGICAL TISSUE | 2017 |
|
RU2643922C1 |
| METHOD FOR STIMULATING SPERMATOGENIC AND ANDROGEN-PRODUCING FUNCTIONS OF MALE GENITAL GLANDS | 1991 |
|
RU2040258C1 |
| AGENT FOR PREVENTING PATHOLOGICAL SKIN SCARS FORMATION | 2018 |
|
RU2691647C1 |
| METHOD FOR PREVENTING PROLIFERATIVE VITRIORETINOPATHY DEVELOPING IN RETINAL DETACHMENT IN EXPERIMENT ON RATS | 2018 |
|
RU2689324C1 |
| COMPOSITION FOR PREVENTING AND TREATING INFLAMMATORY DISEASES OF ORAL CAVITY | 2019 |
|
RU2716501C1 |
| METHOD FOR SIMULATION OF HYPOGONADISM CAUSED BY METABOLIC DISORDERS | 2016 |
|
RU2611936C1 |
| SAMPLE FIXATOR FOR CYTOLOGICAL EXAMINATION | 2016 |
|
RU2630983C1 |
| METHOD FOR TREATMENT OF ADOLESCENT HYPOGONADOTROPIC HYPOGONADISM IN EXPERIMENT | 2020 |
|
RU2750713C1 |
